288 related articles for article (PubMed ID: 9553528)
1. Medical management of osteoporosis. Fracture prevention.
Brunelli MP; Einhorn TA
Clin Orthop Relat Res; 1998 Mar; (348):15-21. PubMed ID: 9553528
[TBL] [Abstract][Full Text] [Related]
2. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 9. Calcitonin in the treatment of osteoporosis.
Siminoski K; Josse RG
CMAJ; 1996 Oct; 155(7):962-5. PubMed ID: 8837547
[TBL] [Abstract][Full Text] [Related]
3. Osteoporosis management.
Rozenberg S; Vandromme J; Ayata NB; Filippidis M; Kroll M
Int J Fertil Womens Med; 1999; 44(5):241-9. PubMed ID: 10569453
[TBL] [Abstract][Full Text] [Related]
4. [Quality of life of patients suffering from osteoporosis treated with alendronate and salmon calcitonin].
Sapuła RA; Ostrowski T; Bojar I
Wiad Lek; 2002; 55 Suppl 1():444-7. PubMed ID: 15002282
[TBL] [Abstract][Full Text] [Related]
5. Risk of fracture and treatment to prevent osteoporosis-related fracture in postmenopausal women. A review.
Martens MG
J Reprod Med; 2003 Jun; 48(6):425-34. PubMed ID: 12856513
[TBL] [Abstract][Full Text] [Related]
6. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
Ettinger MP
Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
[TBL] [Abstract][Full Text] [Related]
7. Hip fracture patients are not treated for osteoporosis: a call to action.
Harrington JT; Broy SB; Derosa AM; Licata AA; Shewmon DA
Arthritis Rheum; 2002 Dec; 47(6):651-4. PubMed ID: 12522840
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis, prevention, and treatment of osteoporosis in men.
Epperly TD; Moore KE
J Gend Specif Med; 2002; 5(6):33-8. PubMed ID: 12503224
[TBL] [Abstract][Full Text] [Related]
9. Medical therapy of osteoporosis.
Weinerman SA; Bockman RS
Orthop Clin North Am; 1990 Jan; 21(1):109-24. PubMed ID: 2404231
[TBL] [Abstract][Full Text] [Related]
10. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
[TBL] [Abstract][Full Text] [Related]
11. The treatment of osteoporosis. Antiresorptive therapy.
Miller PD
Clin Lab Med; 2000 Sep; 20(3):603-22, viii. PubMed ID: 10986624
[TBL] [Abstract][Full Text] [Related]
12. Management of osteoporosis due to ovarian failure.
Eastell R
Med Pediatr Oncol; 2003 Sep; 41(3):222-7. PubMed ID: 12868123
[TBL] [Abstract][Full Text] [Related]
13. Guidelines for the management of postmenopausal osteoporosis for GPs.
O'Neill S; MacLennan A; Bass S; Diamond T; Ebeling P; Findlay D; Flicker L; Markwell A; Nowson C; Pocock N; Sambrook P; Singh MF;
Aust Fam Physician; 2004 Nov; 33(11):910-9. PubMed ID: 15584331
[TBL] [Abstract][Full Text] [Related]
14. American Association of Clinical Endocrinologists 2001 Medical Guidelines for Clinical Practice for the Prevention and Management of Postmenopausal Osteoporosis.
American Association of Clinical Endocrinologists Osteoporosis Task Force
Endocr Pract; 2001; 7(4):293-312. PubMed ID: 11508261
[No Abstract] [Full Text] [Related]
15. Antiresorptive treatment of postmenopausal osteoporosis: review of randomized clinical studies and rationale for the Evista alendronate comparison (EVA) trial.
Lufkin EG; Sarkar S; Kulkarni PM; Ciaccia AV; Siddhanti S; Stock J; Plouffe L
Curr Med Res Opin; 2004 Mar; 20(3):351-7. PubMed ID: 15025844
[TBL] [Abstract][Full Text] [Related]
16. [Possibilities of non-hormonal drug treatment of osteoporosis].
Szathmári M; Châtel R
Orv Hetil; 1999 Sep; 140(38):2091-100. PubMed ID: 10531790
[TBL] [Abstract][Full Text] [Related]
17. Prevention of osteoporosis and fractures.
Ullom-Minnich P
Am Fam Physician; 1999 Jul; 60(1):194-202. PubMed ID: 10414638
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.
Iwamoto J; Takeda T; Sato Y
Curr Med Res Opin; 2006 May; 22(5):919-28. PubMed ID: 16709313
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutic strategies for osteoporosis].
Chapurlat R; Delmas PD
Ann Med Interne (Paris); 2000 Oct; 151(6):471-6. PubMed ID: 11104926
[TBL] [Abstract][Full Text] [Related]
20. [Clinic effect of alendronate sodium treatment in osteoporosis patients with hip fracture].
Qiu GX; Wu ZH; Shen JX; Luo XZ; Tang H; Wang YP; Weng XS; Yang XY; Lin J; Jin J; Zhao H; Tian Y; Zhang JG
Zhonghua Wai Ke Za Zhi; 2004 Mar; 42(6):347-50. PubMed ID: 15144688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
